Vold Vision P.L.L.C.
Fayetteville, Arkansas, 72764, United States
NCT Number: NCT04619654
This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.
Looking for future studies?
Notify Me45 year and older
All sexes
Interventional
Not applicable
Fayetteville, Arkansas, 72764, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cataract surgery with implantation of the PanOptix IOL combined with minimally invasive glaucoma surgery utilizing the Hydrus Microstent
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Difference from postoperative refraction from preoperative biometry
Time frame: 3 months
Grading of dysphotopsia
Time frame: 3 months
Gauging spectacle independence postoperatively
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Vold Vision P.L.L.C
Other
Visual Acuity, Refractive Predictability, and Patient Reported Quality of Vision in Subjects Implanted With a Trifocal IOL With Stable Mild Open-Angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04476810
Angle Closure Glaucoma, Cataract
Dammam, Saudi Arabia
View Trial DetailsNCT04202562
Cardiovascular Diseases, Cataract
Madrid, Spain
View Trial DetailsNCT05624398
Cataract, Eye Diseases
Fayetteville, Arkansas, United States
View Trial DetailsNCT04430647
Cataract, Eye Diseases
Al Mansurah, Dakahlia Governorate, Egypt
View Trial Details